Cytotoxicity Enhancement in MCF-7 Breast Cancer Cells with Depolymerized Chitosan Delivery of α-Mangostin

Overview

Journal Polymers (Basel)

Publisher MDPI

Date 2022 Aug 12

PMID 35956654

Authors

Yedi Herdiana

Nasrul Wathoni

Shaharum Shamsuddin

Muchtaridi Muchtaridi

Affiliations

Soon will be listed here.

Abstract

The application of α-mangostin (AMG) in breast cancer research has wide intentions. Chitosan-based nanoparticles (CSNPs) have attractive prospects for developing anticancer drugs, especially in their high flexibility for modification to enhance their anticancer action. This research aimed to study the impact of depolymerized chitosan (CS) on the cytotoxicity enhancement of AMG in MCF-7 breast cancer cells. CSNPs effectivity depends on size, shape, crystallinity degree, and charge surface. Modifying CS molecular weight (MW) is expected to influence CSNPs' characteristics, impacting size, shape, crystallinity degree, and charge surface. CSNPs are developed using the method of ionic gelation with sodium tripolyphosphate (TPP) as a crosslinker and spray pyrolysis procedure. Nanoparticles' (NPs) sizes vary from 205.3 ± 81 nm to 450.9 ± 235 nm, ZP charges range from +10.56 mV to +51.56 mV, and entrapment efficiency from 85.35% to 90.45%. The morphology of NPs are all the same spherical forms. In vitro release studies confirmed that AMG-Chitosan-High Molecular Weight (AMG-CS-HMW) and AMG-Chitosan-Low Molecular Weight (AMG-CS-LMW) had a sustained-release system profile. MW has a great influence on surface, drug release, and cytotoxicity enhancement of AMG in CSNPs to MCF-7 cancer cells. The preparations AMG-CS-HMW and AMG-CS-LMW NPs considerably enhanced the cytotoxicity of MCF-7 cells with IC values of 5.90 ± 0.08 µg/mL and 4.90 ± 0.16 µg/mL, respectively, as compared with the non-nano particle formulation with an IC of 8.47 ± 0.29 µg/mL. These findings suggest that CSNPs can enhance the physicochemical characteristics and cytotoxicity of AMG in breast cancer treatment.

Citing Articles

Evaluation of phytochemical composition, antioxidant, cytotoxic and in silico studies of ethyl acetate fractions of leaves.

Situmeang B, Swasono R, Raharjo T Toxicol Rep. 2025; 14:101911.

PMID: 39897399 PMC: 11787705. DOI: 10.1016/j.toxrep.2025.101911.

Cytotoxicity Enhancement of α-Mangostin with Folate-Conjugated Chitosan Nanoparticles in MCF-7 Breast Cancer Cells.

Herdiana Y, Wathoni N, Shamsuddin S, Muchtaridi M Molecules. 2023; 28(22).

PMID: 38005306 PMC: 10674958. DOI: 10.3390/molecules28227585.

Preparation of water-soluble chitosan oligosaccharides by oxidative hydrolysis of chitosan powder with hydrogen peroxide.

Nguyen T, Tuan Le N, Tran P, Bui D, Nguyen Q Heliyon. 2023; 9(9):e19565.

PMID: 37681167 PMC: 10480655. DOI: 10.1016/j.heliyon.2023.e19565.

Chitosan-Based Nano Systems for Natural Antioxidants in Breast Cancer Therapy.

Herdiana Y, Husni P, Nurhasanah S, Shamsuddin S, Wathoni N Polymers (Basel). 2023; 15(13).

PMID: 37447598 PMC: 10347152. DOI: 10.3390/polym15132953.

Chitosan-Based Nano-Smart Drug Delivery System in Breast Cancer Therapy.

Herdiana Y, Wathoni N, Gozali D, Shamsuddin S, Muchtaridi M Pharmaceutics. 2023; 15(3).

PMID: 36986740 PMC: 10051865. DOI: 10.3390/pharmaceutics15030879.

References

Aibani N, Rai R, Patel P, Cuddihy G, Wasan E . Chitosan Nanoparticles at the Biological Interface: Implications for Drug Delivery. Pharmaceutics. 2021; 13(10). PMC: 8540112. DOI: 10.3390/pharmaceutics13101686. View

Kamaly N, Yameen B, Wu J, Farokhzad O . Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release. Chem Rev. 2016; 116(4):2602-63. PMC: 5509216. DOI: 10.1021/acs.chemrev.5b00346. View

Alhajj N, Zakaria Z, Naharudin I, Ahsan F, Li W, Wong T . Critical physicochemical attributes of chitosan nanoparticles admixed lactose-PEG 3000 microparticles in pulmonary inhalation. Asian J Pharm Sci. 2020; 15(3):374-384. PMC: 7327774. DOI: 10.1016/j.ajps.2019.02.001. View

Caro-Leon F, Arguelles-Monal W, Carvajal-Millan E, Lopez-Franco Y, Goycoolea-Valencia F, San Roman Del Barrio J . Production and characterization of supercritical CO dried chitosan nanoparticles as novel carrier device. Carbohydr Polym. 2018; 198:556-562. DOI: 10.1016/j.carbpol.2018.06.102. View

Dasgupta S, Auth T, Gompper G . Shape and orientation matter for the cellular uptake of nonspherical particles. Nano Lett. 2014; 14(2):687-93. DOI: 10.1021/nl403949h. View

Luo J, Sun J, Luo X, Wei Y, Zheng H, Mu C . Low molecular weight chitosan-based conjugates for efficient Rhein oral delivery: synthesis, characterization, and pharmacokinetics. Drug Dev Ind Pharm. 2018; 45(1):96-104. DOI: 10.1080/03639045.2018.1522326. View

Bruinsmann F, Pigana S, Aguirre T, Souto G, Garrastazu Pereira G, Bianchera A . Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery. Pharmaceutics. 2019; 11(2). PMC: 6409859. DOI: 10.3390/pharmaceutics11020086. View

Cao M, Luo X, Wu K, He X . Targeting lysosomes in human disease: from basic research to clinical applications. Signal Transduct Target Ther. 2021; 6(1):379. PMC: 8572923. DOI: 10.1038/s41392-021-00778-y. View

Lima K, Pinilla C, Aleman A, Lopez-Caballero M, Gomez-Guillen M, Montero P . Characterization, Bioactivity and Application of Chitosan-Based Nanoparticles in a Food Emulsion Model. Polymers (Basel). 2021; 13(19). PMC: 8512445. DOI: 10.3390/polym13193331. View

10.

Herdiana Y, Wathoni N, Shamsuddin S, Muchtaridi M . Drug release study of the chitosan-based nanoparticles. Heliyon. 2022; 8(1):e08674. PMC: 8741465. DOI: 10.1016/j.heliyon.2021.e08674. View

11.

Ma Z, Wang W, Wu Y, He Y, Wu T . Oxidative degradation of chitosan to the low molecular water-soluble chitosan over peroxotungstate as chemical scissors. PLoS One. 2014; 9(6):e100743. PMC: 4074069. DOI: 10.1371/journal.pone.0100743. View

12.

Tan S, Billa N . Improved Bioavailability of Poorly Soluble Drugs through Gastrointestinal Muco-Adhesion of Lipid Nanoparticles. Pharmaceutics. 2021; 13(11). PMC: 8620210. DOI: 10.3390/pharmaceutics13111817. View

13.

George B, Chandran R, Abrahamse H . Role of Phytochemicals in Cancer Chemoprevention: Insights. Antioxidants (Basel). 2021; 10(9). PMC: 8466984. DOI: 10.3390/antiox10091455. View

14.

Herdiana Y, Handaresta D, Joni I, Wathoni N, Muchtaridi M . Synthesis of nano-α mangostin based on chitosan and Eudragit S 100. J Adv Pharm Technol Res. 2020; 11(3):95-100. PMC: 7574733. DOI: 10.4103/japtr.JAPTR_182_19. View

15.

Ashrafizadeh M, Delfi M, Hashemi F, Zabolian A, Saleki H, Bagherian M . Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy. Carbohydr Polym. 2021; 260:117809. DOI: 10.1016/j.carbpol.2021.117809. View

16.

Patra J, Das G, Fraceto L, Campos E, Del Pilar Rodriguez-Torres M, Acosta-Torres L . Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018; 16(1):71. PMC: 6145203. DOI: 10.1186/s12951-018-0392-8. View

17.

de Farias B, Grundmann D, Rizzi F, Martins N, SantAnna Cadaval Junior T, Pinto L . Production of low molecular weight chitosan by acid and oxidative pathways: Effect on physicochemical properties. Food Res Int. 2019; 123:88-94. DOI: 10.1016/j.foodres.2019.04.051. View

18.

Asasutjarit R, Meesomboon T, Adulheem P, Kittiwisut S, Sookdee P, Samosornsuk W . Physicochemical properties of alpha-mangostin loaded nanomeulsions prepared by ultrasonication technique. Heliyon. 2019; 5(9):e02465. PMC: 6745438. DOI: 10.1016/j.heliyon.2019.e02465. View

19.

Aggarwal N, Yadav J, Chhakara S, Janjua D, Tripathi T, Chaudhary A . Phytochemicals as Potential Chemopreventive and Chemotherapeutic Agents for Emerging Human Papillomavirus-Driven Head and Neck Cancer: Current Evidence and Future Prospects. Front Pharmacol. 2021; 12:699044. PMC: 8329252. DOI: 10.3389/fphar.2021.699044. View

20.

Cheng J, Zhu H, Huang J, Zhao J, Yan B, Ma S . The physicochemical properties of chitosan prepared by microwave heating. Food Sci Nutr. 2020; 8(4):1987-1994. PMC: 7174223. DOI: 10.1002/fsn3.1486. View